Back to Peptide Encyclopedia
Sexual FunctionApproved
PT-141
Bremelanotide / Vyleesi
Melanocortin peptide approved for sexual dysfunction.
Prescription2 protocols
Approved by FDA only — not in all jurisdictions
·Educational information. Not medical advice or a recommendation for use.Key Facts: PT-141
Category
Sexual Function
Evidence
Approved
Availability
Prescription
Protocols
2
Research Overview & Mechanisms
Activates MC4R in the CNS, affecting sexual arousal.
Reported Research Benefits
Sexual function
Libido
Available Protocols
Frequently Asked Questions
FAQ
Melanocortin peptide approved for sexual dysfunction.
Advanced Compound Intelligence
—
Human studies
—
Key studies
—
Interactions
Approved
Evidence tier
Verified intelligence
Research summaryClinical Evidence
Approved
View all studies on PubMedApproved by regulatory agencies (FDA/EMA) with extensive Phase III clinical trial data.
Scientific Sources & Further Reading
Explore peer-reviewed research about PT-141:
External links open in new tabs. Always verify information with qualified healthcare providers.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →